Cargando…
Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma
Glioblastoma (GBM), a primary malignant tumor of the central nervous system, has a very poor prognosis. Analysis of global GBM samples has revealed a variety of long non-coding RNAs (lncRNAs) associated with prognosis; nevertheless, there remains a lack of accurate prognostic markers. Using RNA-Seq,...
Autores principales: | Li, Mingdong, Long, Shengrong, Hu, Jinqu, Wang, Zan, Geng, Chao, Ou, Shaowu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874448/ https://www.ncbi.nlm.nih.gov/pubmed/31692451 http://dx.doi.org/10.18632/aging.102393 |
Ejemplares similares
-
Thrombospondin-1 is a prognostic biomarker and is correlated with tumor immune microenvironment in glioblastoma
por: Qi, Chunxiao, et al.
Publicado: (2021) -
Construction of lncRNA-mediated ceRNA network to reveal clinically relevant lncRNA biomarkers in glioblastomas
por: Zan, Xiang-Yang, et al.
Publicado: (2019) -
T cell immune regulator 1 is a prognostic marker associated with immune infiltration in glioblastoma multiforme
por: Qi, Chunxiao, et al.
Publicado: (2021) -
Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma
por: Yu, Wanli, et al.
Publicado: (2021) -
Identification and characterization of lncRNA mediated transcriptional dysregulation dictates lncRNA roles in glioblastoma
por: Li, Yongsheng, et al.
Publicado: (2016)